FDA Import Refusal AEK-8226601-4/11/1 — ABBVIE CARE
The FDA refused shipment AEK-8226601-4/11/1 from ABBVIE CARE (Canada) on Feb 13, 2025. The refused product falls under Drugs and Biologics — RISANKIZUMAB-RZAA. Cited charge: 75 This firm has 3 other import refusals on record.
Refusal details
- Date
- Feb 13, 2025
- Country
- Canada
- Product Category
- Drugs and Biologics
- Product Code
- 58MDY09 RISANKIZUMAB-RZAA
- Charges
- 75